YAP1 and cancer: Given the clear profibrotic effect of YAP/TAZ, such pharmacological inhibitors targeting the Hippo pathway may be beneficial for treating both fibrosis and cancer (Table 1) [69,79,158,159,160,161,162,163,164,165].